Background
Antibiotic susceptibility pattern of 540 Staphylococcus lugdunensis isolates tested with the disc diffusion method:[2]
Antibiotic |
No. (%) susceptible
|
Penicillin G |
403 (74.6)
|
Gentamicin |
538 (99.6)
|
Rifampicin |
538 (99.6)
|
Cefoxitin |
538 (99.6)
|
Fusidic acid |
528 (97.8)
|
Trimethoprim/sulfamethoxazole |
539 (99.8)
|
Norfloxacin |
539 (99.8)
|
Clindamycin |
494 (91.5)
|
Erythromycin |
506 (93.7)
|
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
See Also
References
- ↑ Taha L, Stegger M, and Soderquist B. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options, European Journal of Clinical Microbiology & Infectious Diseases, May 2019. Accessed 21 December 2020.
- ↑ Taha L, Stegger M, and Soderquist B. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options, European Journal of Clinical Microbiology & Infectious Diseases, May 2019. Accessed 21 December 2020.
- ↑ Sanford Guide to Antimicrobial Therapy 2010